If you need more lookups,
subscriptions start at $34 USD/month.
Thomas Morel Location
Basel, BS, CH
Thomas Morel Work
2017 -now Patient-Centred Outcomes Research and Policy Lead, Global Clinical Development @
2013 -2017 Associate Director, Early Products Market Access and PRO Strategy @
2023 -2025 Industry Chair, Critical Path Parkinson's Patient-Centric Endpoints Group @
2019 -2025 Member of the Therapies Scientific Committee (TSC) @
2019 -2022 Member - Innovative methodologies for clinical studies in rare diseases taskforce @ European Joint Programme on Rare Diseases
2011 -2022 Research Fellow, Clinical Pharmacology and Pharmacotherapy @
2018 -2019 Taskforce member - Orphan Drug Development Guidebook @
2016 -2017 Team Lead - Taskforce on Patient-Centered Outcome Measures in Rare Diseases @
2007 -2013 Manager, Health Economics and Outcomes Research group @
2003 -2007 EU public affairs consultant @ Houston Consulting Europe
Thomas Morel Education
KU Leuven 2014-2019
King's College London 2004-2005
The London School of Economics and Political Science (LSE) 2001-2002
Thomas Morel Summary
Thomas Morel, based in Basel, BS, CH, is currently a Patient-Centred Outcomes Research and Policy Lead, Global Clinical Development at UCB. Thomas Morel brings experience from previous roles at UCB, Critical Path Institute (C-Path), International Rare Diseases Research Consortium (IRDiRC) and European Joint Programme on Rare Diseases. Thomas Morel holds a 2014 - 2019 KU Leuven. Thomas Morel has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Thomas Morel?
Find contact details for 700 million professionals.